Localization of yttrium 90 ibritumomab tiuxetan (90Y IT) in patients with CD20 + non-Hodgkin’s lymphoma (NHL)
| Autor: | Anthony M. Harrison, Kenneth A. Foon, S. A. Swerdlow, N. Vidnovic, Samuel A. Jacobs, Norbert Avril, Kenneth S. McCarty |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Oncology
CD20 Cancer Research medicine.medical_specialty Yttrium-90 Ibritumomab Tiuxetan biology business.industry Ibritumomab tiuxetan medicine.disease Non-Hodgkin's lymphoma Refractory Internal medicine medicine biology.protein Effective treatment In patient Nuclear medicine business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 23:2547-2547 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2005.23.16_suppl.2547 |
| Popis: | 2547 Background: Yttrium-90 ibritumomab tiuxetan (90Y IT, Zevalin) is effective treatment for relapsed or refractory low-grade, follicular, or transformed B-cell NHL although affected lymph nodes m... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|